Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer.

J Breast Cancer · 2015 · PMC4600692 · PMID 26472978

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

did not reach statistical significancep =0.058so close (0.05 < p ≤ 0.1)

Compared to the T1 stage, T2 showed a greater risk of death but this result did not reach statistical significance ( p =0.058).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.